Axogen, Inc. (AXGN) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Axogen, Inc.

NeuroPace, Inc.

Sanara MedTech, Inc.

Anika Therapeutics, Inc.

ZimVie, Inc.

AVITA Medical, Inc.

Standard BioTools, Inc.

Allurion Technologies, Inc.

Accuray, Inc.

Pulse Biosciences, Inc.

Alpha Tau Medical Ltd.

Why is Axogen, Inc. ?

With a growth in Operating Profit of 754.39%, the company declared Very Positive results in Jun 25

OPERATING CASH FLOW(Y) Highest at USD 7.19 MM
ROCE(HY) Highest at -4.48%
INVENTORY TURNOVER RATIO(HY) Highest at 1.61 times

High Institutional Holdings at 99.72%

These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Their stake has increased by 5.88% over the previous quarter.

Market Beating performance in long term as well as near term

Along with generating 110.24% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Axogen, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Axogen, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Axogen, Inc.

127.53%

4.98

61.16%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

14.54%

EBIT Growth (5y)

15.48%

EBIT to Interest (avg)

-13.30

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.21

Sales to Capital Employed (avg)

1.15

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

99.72%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.72

EV to EBIT

-519.08

EV to EBITDA

70.69

EV to Capital Employed

4.08

EV to Sales

2.67

PEG Ratio

Dividend Yield

ROCE (Latest)

-0.38%

ROE (Latest)

-7.14%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

21What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD 7.19 MM

ROCE(HY)

Highest at -4.48%

INVENTORY TURNOVER RATIO(HY)

Highest at 1.61 times

PRE-TAX PROFIT(Q)

At USD 0.1 MM has Grown at 105.26%

NET PROFIT(Q)

At USD 0.1 MM has Grown at 105.26%

RAW MATERIAL COST(Y)

Fallen by -0.54% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 7.64 times

NET SALES(Q)

Highest at USD 56.66 MM

EPS(Q)

Highest at USD 0.01

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for Axogen, Inc.

Pre-Tax Profit

At USD 0.1 MM has Grown at 105.26%

over average net sales of the previous four periods of USD -1.88 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit

At USD 0.1 MM has Grown at 105.26%

over average net sales of the previous four periods of USD -1.88 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (USD MM)

Inventory Turnover Ratio

Highest at 1.61 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Operating Cash Flow

Highest at USD 7.19 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales

Highest at USD 56.66 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

EPS

Highest at USD 0.01

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Debtors Turnover Ratio

Highest at 7.64 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -0.54% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales